AstraZeneca Pharma India Limited (NSE:ASTRAZEN)

AstraZeneca Pharma India Statistics

Total Valuation

NSE:ASTRAZEN has a market cap or net worth of INR 250.89 billion. The enterprise value is 245.88 billion.

Market Cap	250.89B
Enterprise Value	245.88B

Important Dates

The last earnings date was Thursday, May 29, 2025.

Earnings Date	May 29, 2025
Ex-Dividend Date	Jul 5, 2024

Share Statistics

Current Share Class	25.00M
Shares Outstanding	n/a
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	4.14M

Valuation Ratios

The trailing PE ratio is 216.77.

PE Ratio	216.77
Forward PE	n/a
PS Ratio	14.62
PB Ratio	32.57
P/TBV Ratio	32.60
P/FCF Ratio	394.43
P/OCF Ratio	383.86
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 96.82, with an EV/FCF ratio of 386.55.

EV / Earnings	212.45
EV / Sales	14.33
EV / EBITDA	96.82
EV / EBIT	114.91
EV / FCF	386.55

Financial Position

The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.05.

Current Ratio	1.91
Quick Ratio	1.03
Debt / Equity	0.05
Debt / EBITDA	0.14
Debt / FCF	0.56
Interest Coverage	146.56

Financial Efficiency

Return on equity (ROE) is 15.62% and return on invested capital (ROIC) is 17.57%.

Return on Equity (ROE)	15.62%
Return on Assets (ROA)	10.30%
Return on Invested Capital (ROIC)	17.57%
Return on Capital Employed (ROCE)	26.25%
Revenue Per Employee	28.60M
Profits Per Employee	1.93M
Employee Count	600
Asset Turnover	1.32
Inventory Turnover	2.48

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +60.77% in the last 52 weeks. The beta is 0.03, so NSE:ASTRAZEN's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	+60.77%
50-Day Moving Average	8,450.61
200-Day Moving Average	7,439.83
Relative Strength Index (RSI)	79.18
Average Volume (20 Days)	150,968

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:ASTRAZEN had revenue of INR 17.16 billion and earned 1.16 billion in profits. Earnings per share was 46.30.

Revenue	17.16B
Gross Profit	7.53B
Operating Income	2.14B
Pretax Income	1.56B
Net Income	1.16B
EBITDA	2.54B
EBIT	2.14B
Earnings Per Share (EPS)	46.30

Balance Sheet

The company has 5.37 billion in cash and 357.30 million in debt, giving a net cash position of 5.01 billion.

Cash & Cash Equivalents	5.37B
Total Debt	357.30M
Net Cash	5.01B
Net Cash Per Share	n/a
Equity (Book Value)	7.70B
Book Value Per Share	308.14
Working Capital	6.39B

Cash Flow

In the last 12 months, operating cash flow was 653.60 million and capital expenditures -17.50 million, giving a free cash flow of 636.10 million.

Operating Cash Flow	653.60M
Capital Expenditures	-17.50M
Free Cash Flow	636.10M
FCF Per Share	n/a

Margins

Gross margin is 43.89%, with operating and profit margins of 12.47% and 6.74%.

Gross Margin	43.89%
Operating Margin	12.47%
Pretax Margin	9.11%
Profit Margin	6.74%
EBITDA Margin	14.80%
EBIT Margin	12.47%
FCF Margin	3.71%

Dividends & Yields

This stock pays an annual dividend of 24.00, which amounts to a dividend yield of 0.25%.

Dividend Per Share	24.00
Dividend Yield	0.25%
Dividend Growth (YoY)	50.00%
Years of Dividend Growth	3
Payout Ratio	51.84%
Buyback Yield	0.01%
Shareholder Yield	0.25%
Earnings Yield	0.46%
FCF Yield	0.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a